$TOCKHOLDER ALERT: The M&A Class Action Firm Continues Its Investigation Into The Merger - BRDG, AKYA, CKPT, QTRX
Nyenta.com/10310047

NEW YORK, April 18, 2025 /PRNewswire/ -- Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. We are headquartered at the Empire State Building in New York City and are investigating:

• Bridge Investment Group Holdings Inc. (NYSE: https://www.prnewswire.com/news-releases/#finan..." rel="nofollow">BRDG), relating to the proposed merger with Apollo. Under the terms of the agreement, Bridge stockholders and Bridge OpCo unitholders will receive 0.07081 shares of Apollo stock for each share of Bridge Class A common stock and each Bridge OpCo Class A common unit, respectively.

Click here for more https://monteverdelaw.com/case/bridge-investment-group-holdings-inc-brdg/. It is free and there is no cost or obligation to you.

• Akoya Biosciences, Inc. (NASDAQ: https://www.prnewswire.com/news-releases/#finan..." rel="nofollow">AKYA), relating to the proposed merger with Quanterix. Under the terms of the agreement, Akoya shareholders will receive 0.318 shares of Quanterix common stock for each share of Akoya common stock owned. Akoya shareholders will own approximately 30% of the combined company.

ACT NOW. The Shareholder Vote is scheduled for May 13, 2025.

More on Nyenta.com

• CCHR Says Mounting Evidence of Persistent Sexual Dysfunction From Antidepressants Demands FDA Action
• How Truck Dispatch Services Help Owner-Operators Increase Weekly Profits
• Members Heritage Credit Union Taps Scienaptic AI to Power Frictionless, Inclusive Credit Decisions and Transform Lending
• Rigani Press Announces Ebook Version Now Available for RUSHING HEADLONG by S. Yin Ho
• Mom of Two Turns Parenting Frustration Into Viral Baby Product

Click here for more https://monteverdelaw.com/case/akoya-biosciences-inc-akya/. It is free and there is no cost or obligation to you.

• Checkpoint Therapeutics, Inc. (NASDAQ: https://www.prnewswire.com/news-releases/#finan..." rel="nofollow">CKPT), relating to the proposed merger with Sun Pharmaceutical Industries Limited. Under the terms of the agreement, Checkpoint stockholders will receive, for each share of common stock they hold, a cash payment of $4.10, and a non-transferable contingent value right entitling the stockholder to receive up to $0.70 in cash.

Click here for more https://monteverdelaw.com/case/checkpoint-therapeutics-inc-ckpt/. It is free and there is no cost or obligation to you.

• Quanterix Corporation (NASDAQ: https://www.prnewswire.com/news-releases/#finan..." rel="nofollow">QTRX), relating to the proposed merger with Akoya Biosciences. Under the terms of the agreement, Akoya shareholders will be given 0.318 shares of Quanterix common stock for each share of Akoya common stock owned.

ACT NOW. The Shareholder Vote is scheduled for May 13, 2025.

Click here for more https://monteverdelaw.com/case/quanterix-corporation-qtrx/. It is free and there is no cost or obligation to you.

More on Nyenta.com

• New Analysis Reveals Most Patients Discontinue Weight Loss Drugs Within First Year
• The new geography of global wealth: why investors are shifting capital to more stable financial hubs
• Djamee Raphaël Unveils Official Music Video for Donna Summer Cover, "This Time I Know It's For Real
• Long Island Soccer Player Hall of Fame Gala - Postponed
• International Law Group Expands Emergency Immigration Consultations for Somali Minnesotans Amid ICE Actions

NOT ALL LAW FIRMS ARE THE SAME. Before you hire a law firm, you should talk to a lawyer and ask:

1. Do you file class actions and go to Court?
2. When was the last time you recovered money for shareholders?
3. What cases did you recover money in and how much?

About Monteverde & Associates PC

Our firm litigates and has recovered money for shareholders…and we do it from our offices in the Empire State Building. We are a national class action securities firm with a successful track record in trial and appellate courts, including the U.S. Supreme Court.

No company, director or officer is above the law. If you own common stock in any of the above listed companies and have concerns or wish to obtain additional information free of charge, please visit our website or contact Juan Monteverde, Esq. either via e-mail at [email protected] or by telephone at (212) 971-1341.

Contact:
Juan Monteverde, Esq.
MONTEVERDE & ASSOCIATES PC
The Empire State Building
350 Fifth Ave. Suite 4740
New York, NY 10118
United States of America
[email protected]
Tel: (212) 971-1341

Attorney Advertising. (C) 2025 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter.

SOURCE Monteverde & Associates PC

---

Show All News | Report Violation